Healthcare: Introduction
Segments
Dental Practices and Supplies
This segment is focused upon providing general as well as cosmetic dental services. Also included is equipment, instruments, and supplies used by dentists such as hand instruments, plaster, drills, sterilizers, and dental chairs.
Medical Equipment and Apparatuses
This segment is made up of electro-medical equipment and irradiation apparatuses. Products from this segment include a variety of powered devices, such as pacemakers, patient-monitoring systems, MRI machines, and ultrasonic scanning devices.
Surgical Appliances and Instruments
This segment includes various appliances and instruments used in surgery, such as anesthesia apparatuses, orthopedic instruments, artificial joints and limbs, hydrotherapy appliances, blood transfusion devices, and hypodermic needles.
The Healthcare industry is Highly Fragmented. The production in this industry is divided among many different companies, no single firm has large enough share of the market to be able to influence the industry's direction or price levels.
Primary Demand Drivers
- Demographics
- Advances in medical care and technology
Profitability Drivers
- Obtaining grants and federal funds
- Efficient operations
From the Blog 
Healthcare is a realm where even the smallest decision can impact a person’s life or death. In recent years, the intersection of artificial intelligence (AI) and healthcare has been innovating quickly, transforming various aspects of the medical field. In terms of electronic health records (EHRs), integrating AI is one of the most significant advancements.
Pfizer, a major pharmaceutical company, recently witnessed a substantial fall in its third-quarter sales. The primary reason was a drop in COVID-19 vaccine sales, as well as other related products, resulting in a massive loss of $2.4 billion. Compared to previous years, when the company enjoyed a large profit of $8.6 billion, this fall is substantial. Even though the company foresaw these obstacles and amended their plans, sales toppled by a staggering 42%; yet, Pfizer isn't losing hope. They are looking towards their long-term projects, and count on their resources to pull through in sustainable ways.
Sources
- SelectUSA (Date Accessed: 6/1/2017)